Objectives: Idiopathic hypogonadotropic hypogonadism (IHH) can be associated with anosmia/hyposmia. The objective of this study is to evaluate olfaction by Indian smell identification test (INSIT) and measure olfactory bulbs (OBs) and sulci using dedicated magnetic resonance imaging (MRI) in patients with IHH and correlate MRI findings with INSIT.

Methods: Forty patients with IHH underwent (a) brief smell identification test (INSIT) and (b) MRI of the olfactory apparatus. The size of olfactory sulcus and bulb was quantified and compared with the normative data obtained in 22 controls. The agreement between INSIT and MRI was assessed using Kappa index.

Results: Of the 40 patients, 8 patients who reported abnormal smell sensation and 12 of the remaining 32 patients who reported normal smell sensation historically had a low score on INSIT. Thus, there were 20 patients with Kallmann syndrome (KS) and the rest 20 were normosmic IHH (nIHH). Of 40 patients with IHH, MRI finding was suggestive of normal ( = 16), hypoplastic ( = 12), and aplastic ( = 12) olfactory apparatus. All 20 patients with KS have olfactory abnormalities ( = 12 aplastic, = 8 hypoplastic), and 4 of 20 nIHH have olfactory abnormalities (hypoplastic only) on MRI. There is (a) significant positive correlation ( = 0.54, = 0.013) between the OB volume (MRI) and smell test scores and (b) moderate agreement (Kappa index: 0.49) between smell defect (INSIT score ≤ 4) and aplastic olfactory apparatus.

Conclusion: Self-reporting of smell significantly underestimates olfactory phenotype, and hence we recommend an objective smell test to differentiate KS from nIHH. Olfactory phenotype significantly correlates with MRI quantification of olfactory apparatus in IHH.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683694PMC
http://dx.doi.org/10.4103/ijem.IJEM_28_19DOI Listing

Publication Analysis

Top Keywords

olfactory apparatus
16
olfactory phenotype
12
smell identification
12
identification test
12
patients ihh
12
olfactory
11
smell
9
mri
9
indian smell
8
mri olfactory
8

Similar Publications

Devices for the electrical stimulation of the olfactory system: A review.

Biosens Bioelectron

March 2025

Laboratory of Microsystems LMIS1, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.

The loss of olfactory function has a profound impact on quality of life, affecting not only sensory perception but also memory, emotion, and overall well-being. Despite this, advancements in olfactory prostheses have lagged significantly behind those made for vision and hearing restoration. This review offers a comprehensive analysis of the current state of devices for electrical stimulation of the olfactory system.

View Article and Find Full Text PDF

Exploring air pollution awareness: insights from interviews with technology enthusiasts using wearable monitoring devices.

Front Public Health

December 2024

Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy.

This study aims to investigate shifts in awareness regarding air pollution and its correlation with interest in using wearable devices for air quality monitoring. 16 healthy participants, predominantly engineers, residing or studying in Milan, were interviewed to assess their knowledge and interest in air pollution. Participants then walked a predefined route of 4.

View Article and Find Full Text PDF

Background: Evidence from the fields of evolutionary biology and neuroscience supports the theory that spatial cognition and social cognition share neural mechanisms. Rodent models are widely used to study either spatial or social cognition, but few studies have explored the interactions between the spatial and social cognitive domains due to the lack of appropriate paradigms.

New Method: Our study introduces the Vertical Maze (VM), a novel behavioral apparatus designed to measure multiple aspects of spatial and social cognition.

View Article and Find Full Text PDF
Article Synopsis
  • The blood-brain barrier (BBB) makes it difficult to deliver drugs to the central nervous system (CNS), and traditional methods like transnasal delivery have had limited success due to anatomical and physiological challenges.
  • Researchers developed a new technique called the minimally invasive nasal depot (MIND) that allows for precise delivery of drugs directly into the olfactory epithelium, bypassing the BBB.
  • The MIND technique has shown successful delivery of therapeutic oligonucleotides in rat models, leading to positive effects in brain regions associated with neuroprotection, thus holding promise for improved treatments for neurological diseases.
View Article and Find Full Text PDF

Rational development of fingolimod nano-embedded microparticles as nose-to-brain neuroprotective therapy for ischemic stroke.

Drug Deliv Transl Res

November 2024

Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, L2-08B, 2/F, Laboratory Block, 21 Sassoon Road, Pokfulam, Hong Kong SAR, China.

Ischemic stroke is one of the major diseases causing varying degrees of dysfunction and disability worldwide. The current management of ischemic stroke poses significant challenges due to short therapeutic windows and limited efficacy, highlighting the pressing need for novel neuroprotective treatment strategies. Previous studies have shown that fingolimod (FIN) is a promising neuroprotective drug.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!